Interleukin (IL)-33: New Therapeutic Target for Atopic Diseases
Abstract.: Interleukin (IL)-33, a member of the IL-1 family of cytokines, is produced when epithelial and endothelial cells are exposed to stimuli. Hematopoietic cells such as macrophages also produce IL-33. IL-33 is considered to function as an 'alarmin', activating various immune cells t...
Saved in:
Main Author: | Takeshi Nabe (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of interleukin-1ß and interleukin-33 in atopic dermatitis
by: Rania M. Abdel Hay, et al.
Published: (2013) -
comment: The role of interleukin-1ß and interleukin-33 in atopic dermatitis
by: Miloš Jeseňák
Published: (2013) -
Allergen-specific immunoglobulin E and interleukin 33 in atopic dermatitis
by: Małgorzata Bernacka, et al.
Published: (2019) -
Protein and mRNA expression of interleukin-33 in periodontally diseased and healthy individuals and impact of nonsurgical periodontal therapy in salivary IL-33 levels
by: Ambili Renjith, et al.
Published: (2023) -
Interleukin-33 Biology in Tissue Development, Homeostasis and Disease
Published: (2020)